• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of annrheumdAnnals of the Rheumatic DiseasesCurrent TOCInstructions for authors
Ann Rheum Dis. Oct 2003; 62(10): 983–990.
PMCID: PMC1754310

IFNγ deficient C57BL/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vß6 and Vß8 in arthritic joints

Abstract

Background: Transgenic deficiency in interferon γ (IFNγ) or IFNγ receptor makes resistant strains of mice bearing H-2b or H-2d susceptible to collagen induced arthritis (CIA).

Objective: To determine whether the escape from regulation of disease susceptibility at the major histocompatibility complex level involves a new use of autoimmune T cells expressing T cell receptor (TCR) Vß that vary from the cell populations previously identified within arthritic joints.

Methods: Arthritis was induced by a standard protocol with type II bovine collagen (CII) in complete Freund's adjuvant. Clinical features, histopathology, immunological responses, and TCR profile in arthritic joints in IFNγ knockout C57BL/6 (B6.IFNγ KO) mice (H-2b) were compared directly with those in DBA/1 mice (H-2q).

Results: 60–80% of B6.IFNγ KO mice developed a progressive arthritis with a similar clinical course to classical CIA in DBA/1 mice. The affected joints in B6.IFNγ KO mice had an erosive form of arthritis with similar features to joint disease in DBA/1 mice. B6.IFNγ KO mice produced significantly higher levels of IgG2b and IgG1 autoantibodies to murine CII and showed increased proliferative response to CII compared with B6 mice. Comparable levels of interleukin 1ß and tumour necrosis factor α expression were detected in arthritic joints from ß6.IFNγ KO and DBA/1 mice. B6.IFNγKO mice used predominantly TCR Vß6 and Vß8 in arthritic joints. This TCR Vß profile is similar to that found in DBA/1 mice with CIA.

Conclusions: C57BL/6 mice deficient in IFNγ production can develop arthritis that resembles classical CIA. These data suggest that IFNγ is a key factor mediating susceptibility to CIA.

Full Text

The Full Text of this article is available as a PDF (262K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Wooley PH, Luthra HS, Stuart JM, David CS. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med. 1981 Sep 1;154(3):688–700. [PMC free article] [PubMed]
  • Banerjee S, Haqqi TM, Luthra HS, Stuart JM, David CS. Possible role of V beta T cell receptor genes in susceptibility to collagen-induced arthritis in mice. J Exp Med. 1988 Mar 1;167(3):832–839. [PMC free article] [PubMed]
  • Griffiths MM, Cole BC, Ito J, Harper DS, Anderson GD, Cannon GW, Luthra HS, David CS. T-cell receptors and collagen induced arthritis in H-2r mice. Autoimmunity. 1993;14(3):221–229. [PubMed]
  • Nabozny GH, Bull MJ, Hanson J, Griffiths MM, Luthra HS, David CS. Collagen-induced arthritis in T cell receptor V beta congenic B10.Q mice. J Exp Med. 1994 Aug 1;180(2):517–524. [PMC free article] [PubMed]
  • Ranges GE, Sriram S, Cooper SM. Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J Exp Med. 1985 Sep 1;162(3):1105–1110. [PMC free article] [PubMed]
  • David CS. Genes for MHC, TCR and MIs determine susceptibility to collagen induced arthritis. APMIS. 1990 Jul;98(7):575–584. [PubMed]
  • Myers LK, Seyer JM, Stuart JM, Terato K, David CS, Kang AH. T cell epitopes of type II collagen that regulate murine collagen-induced arthritis. J Immunol. 1993 Jul 1;151(1):500–505. [PubMed]
  • Holmdahl R, Jansson L, Gullberg D, Rubin K, Forsberg PO, Klareskog L. Incidence of arthritis and autoreactivity of anti-collagen antibodies after immunization of DBA/1 mice with heterologous and autologous collagen II. Clin Exp Immunol. 1985 Dec;62(3):639–646. [PMC free article] [PubMed]
  • Cooper SM, Sriram S, Ranges GE. Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-gamma. J Immunol. 1988 Sep 15;141(6):1958–1962. [PubMed]
  • Boissier MC, Chiocchia G, Bessis N, Hajnal J, Garotta G, Nicoletti F, Fournier C. Biphasic effect of interferon-gamma in murine collagen-induced arthritis. Eur J Immunol. 1995 May;25(5):1184–1190. [PubMed]
  • Williams RO, Williams DG, Feldmann M, Maini RN. Increased limb involvement in murine collagen-induced arthritis following treatment with anti-interferon-gamma. Clin Exp Immunol. 1993 May;92(2):323–327. [PMC free article] [PubMed]
  • Nakajima H, Hiyama Y, Takamori H, Tsukada W. Cell-mediated transfer of collagen-induced arthritis in mice and its application to the analysis of the inhibitory effects of interferon-gamma and cyclophosphamide. Clin Exp Immunol. 1993 May;92(2):328–335. [PMC free article] [PubMed]
  • Manoury-Schwartz B, Chiocchia G, Bessis N, Abehsira-Amar O, Batteux F, Muller S, Huang S, Boissier MC, Fournier C. High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. J Immunol. 1997 Jun 1;158(11):5501–5506. [PubMed]
  • Vermeire K, Heremans H, Vandeputte M, Huang S, Billiau A, Matthys P. Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. J Immunol. 1997 Jun 1;158(11):5507–5513. [PubMed]
  • Ortmann RA, Shevach EM. Susceptibility to collagen-induced arthritis: cytokine-mediated regulation. Clin Immunol. 2001 Jan;98(1):109–118. [PubMed]
  • Wooley PH, Cingel B. Staphylococcal enterotoxin B increases the severity of type II collagen induced arthritis in mice. Ann Rheum Dis. 1995 Apr;54(4):298–304. [PMC free article] [PubMed]
  • Wooley PH, Sud S, Whalen JD, Nasser S. Pristane-induced arthritis in mice. V. Susceptibility to pristane-induced arthritis is determined by the genetic regulation of the T cell repertoire. Arthritis Rheum. 1998 Nov;41(11):2022–2031. [PubMed]
  • Chu CQ, Wittmer S, Dalton DK. Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J Exp Med. 2000 Jul 3;192(1):123–128. [PMC free article] [PubMed]
  • Staines NA, Wooley PH. Collagen arthritis--what can it teach us? Br J Rheumatol. 1994 Sep;33(9):798–807. [PubMed]
  • Guedez YB, Whittington KB, Clayton JL, Joosten LA, van de Loo FA, van den Berg WB, Rosloniec EF. Genetic ablation of interferon-gamma up-regulates interleukin-1beta expression and enables the elicitation of collagen-induced arthritis in a nonsusceptible mouse strain. Arthritis Rheum. 2001 Oct;44(10):2413–2424. [PubMed]
  • Matthys P, Vermeire K, Mitera T, Heremans H, Huang S, Schols D, De Wolf-Peeters C, Billiau A. Enhanced autoimmune arthritis in IFN-gamma receptor-deficient mice is conditioned by mycobacteria in Freund's adjuvant and by increased expansion of Mac-1+ myeloid cells. J Immunol. 1999 Sep 15;163(6):3503–3510. [PubMed]
  • Dalton DK, Haynes L, Chu CQ, Swain SL, Wittmer S. Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. J Exp Med. 2000 Jul 3;192(1):117–122. [PMC free article] [PubMed]
  • Matthys P, Hatse S, Vermeire K, Wuyts A, Bridger G, Henson GW, De Clercq E, Billiau A, Schols D. AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice. J Immunol. 2001 Oct 15;167(8):4686–4692. [PubMed]
  • Watson WC, Townes AS. Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci. J Exp Med. 1985 Dec 1;162(6):1878–1891. [PMC free article] [PubMed]
  • Wooley PH, Luthra HS, Krco CJ, Stuart JM, David CS. Type II collagen-induced arthritis in mice. II. Passive transfer and suppression by intravenous injection of anti-type II collagen antibody or free native type II collagen. Arthritis Rheum. 1984 Sep;27(9):1010–1017. [PubMed]
  • Graham MB, Dalton DK, Giltinan D, Braciale VL, Stewart TA, Braciale TJ. Response to influenza infection in mice with a targeted disruption in the interferon gamma gene. J Exp Med. 1993 Nov 1;178(5):1725–1732. [PMC free article] [PubMed]
  • Myers LK, Terato K, Seyer JM, Stuart JM, Kang AH. Characterization of a tolerogenic T cell epitope of type II collagen and its relevance to collagen-induced arthritis. J Immunol. 1992 Aug 15;149(4):1439–1443. [PubMed]
  • Myers LK, Miyahara H, Terato K, Seyer JM, Stuart JM, Kang AH. Collagen-induced arthritis in B10.RIII mice (H-2r): identification of an arthritogenic T-cell determinant. Immunology. 1995 Apr;84(4):509–513. [PMC free article] [PubMed]
  • Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-gamma. Annu Rev Immunol. 1997;15:749–795. [PubMed]
  • Butler DM, Malfait AM, Mason LJ, Warden PJ, Kollias G, Maini RN, Feldmann M, Brennan FM. DBA/1 mice expressing the human TNF-alpha transgene develop a severe, erosive arthritis: characterization of the cytokine cascade and cellular composition. J Immunol. 1997 Sep 15;159(6):2867–2876. [PubMed]
  • Saggioro D, Rosato A, Esposito G, Rosenberg MP, Harrison J, Felber BK, Pavlakis GN, Chieco-Bianchi L. Inflammatory polyarthropathy and bone remodeling in HTLV-I Tax-transgenic mice. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Mar 1;14(3):272–280. [PubMed]

Figures and Tables

Figure 1
Arthritis in B6.IFNγ KO mice immunised with bovine CII in CFA. (A) An arthritic hind paw of a B6.IFNγ KO mouse at day 3 of arthritis with a clinical score 1. There is substantial erythematous oedema from the ankle through the digits. ...
Figure 2
Natural clinical course of arthritis in B6.IFNγ KO mice. The average clinical score of arthritic mice reflects the clinical severity of an individual arthritic limb and the number of affected limbs. DBA/1 mice exhibited a typical monophasic progressive ...
Figure 3
Histopathology of arthritis in B6.IFNγ KO mice. (A) Section of a hind paw with arthritis at the day of onset showing inflamed synovium with massive infiltrate of mononuclear cells. There is decreased number of chondrocytes in the articular cartilage. ...
Figure 4
Levels of anti-heterologous and autologous CII antibodies in B6.IFNγ KO mice immunised with bovine CII in CFA (n=10 mice in each group). *p<0.01 (B6.IFNγ KO v B6); **p<0.05 (B6.IFNγ KO v B6).
Figure 5
Enhanced proliferation of lymphocytes from CII immunised B6.IFNγ KO mice. Results are representative of three experiments; n=3 in each group.
Figure 6
Expression of cytokines in arthritic joints in B6.IFNγ KO mice. IL1ß and TNFα gene expression was quantified using a quantitative real-time RT-PCR. Levels of IL1ß and TNFα gene expression in arthritic joints in ...
Figure 7
Predominant TCR Vß6 and Vß8 usage in arthritic joints in B6.IFNγ KO mice. Expression of TCR Vß gene expression was determined by quantitative real-time RT-PCR. This composite graph shows individual arthritic mouse samples ...

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Group

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links